Skip to main content

Heron Therapeutics, Inc.

HRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000818033

No open-market purchases or sales by Heron Therapeutics, Inc. insiders were filed in the last 90 days; 163 institutions reported holding it in 13F filings for Q2 2026, worth $57.1M in total; no superinvestor holds it.

13F holders, Q1 2025

Institutional positions in Heron Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
165
+7 vs. Q4 2024
Shares held
124.8M
+10.2M (+8.9%) vs. Q4 2024
Total value
$274.5M
+$99.2M (+56.6%) vs. Q4 2024
New holders
25
50 more added
Sold out
18
47 more reduced

3 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting HRTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2025: 165 institutions
Q1 2021: 193 institutionsQ2 2021: 189 institutionsQ3 2021: 197 institutionsQ4 2021: 200 institutionsQ1 2022: 186 institutionsQ2 2022: 174 institutionsQ3 2022: 186 institutionsQ4 2022: 176 institutionsQ1 2023: 162 institutionsQ2 2023: 149 institutionsQ3 2023: 141 institutionsQ4 2023: 151 institutionsQ1 2024: 161 institutionsQ2 2024: 190 institutionsQ3 2024: 173 institutionsQ4 2024: 161 institutionsQ1 2025: 165 institutionsQ2 2025: 171 institutionsQ3 2025: 172 institutionsQ4 2025: 170 institutionsQ1 2026: 167 institutionsQ2 2026: 163 institutions
Value heldQ1 2025: $274.5M
Q1 2021: $1.48BQ2 2021: $1.61BQ3 2021: $1.16BQ4 2021: $1.07BQ1 2022: $620.5MQ2 2022: $321.6MQ3 2022: $514.2MQ4 2022: $289.5MQ1 2023: $163.1MQ2 2023: $114.7MQ3 2023: $121.9MQ4 2023: $191.2MQ1 2024: $330.5MQ2 2024: $453.7MQ3 2024: $242.4MQ4 2024: $175.8MQ1 2025: $274.5MQ2 2025: $272.1MQ3 2025: $192.4MQ4 2025: $203.2MQ1 2026: $125.6MQ2 2026: $57.1M
Institutions holding HRTX and their total value by quarter
QuarterHoldersValue
Q2 2026163$57.1M
Q1 2026167$125.6M
Q4 2025170$203.2M
Q3 2025172$192.4M
Q2 2025171$272.1M
Q1 2025165$274.5M
Q4 2024161$175.8M
Q3 2024173$242.4M
Q2 2024190$453.7M
Q1 2024161$330.5M
Q4 2023151$191.2M
Q3 2023141$121.9M
Q2 2023149$114.7M
Q1 2023162$163.1M
Q4 2022176$289.5M
Q3 2022186$514.2M
Q2 2022174$321.6M
Q1 2022186$620.5M
Q4 2021200$1.07B
Q3 2021197$1.16B
Q2 2021189$1.61B
Q1 2021193$1.48B

Institutions, Q1 2025

Shares, value and share of portfolio for each institution holding Heron Therapeutics, Inc.; share changes are against Q4 2024.

Institutions holding HRTX in Q1 2025
InstitutionSharesValue% of portfolioChange in sharesAction
XTX Topco Ltd84,405$185.7K0.01%−213,080−71.6%Reduced
Deutsche Bank AG85,610$188.3K0.00%+25,824+43.2%Added
Searle & Co.86,250$189.8K0.05%00.0%Unchanged
Headlands Technologies LLC92,558$203.6K0.02%+66,886+260.5%Added
Integrated Wealth Concepts LLC94,305$207.5K0.00%−16,778−15.1%Reduced
Creative Planning98,452$216.6K0.00%+98,452New
Biltmore Family Office, LLC101,467$223.2K0.04%00.0%Unchanged
Principal Financial Group Inc115,318$253.7K0.00%+1,758+1.5%Added
Invesco Ltd.119,662$263.3K0.00%+48,263+67.6%Added
Palumbo Wealth Management LLC124,103$273.0K0.09%+124,103New
Raymond James Financial Inc136,222$299.7K0.00%+500+0.4%Added
Capital Planning Advisors, LLC138,095$303.8K0.05%+31,530+29.6%Added
Anfield Capital Management, LLC141,185$310.6K0.11%+22,209+18.7%Added
UBS Group AG158,739$349.2K0.00%−737−0.5%Reduced
Rhumbline Advisers172,094$378.6K0.00%−5,587−3.1%Reduced
Barclays PLC182,546$401.6K0.00%−58,800−24.4%Reduced
Alliancebernstein L.P.198,550$436.8K0.00%00.0%Unchanged
Susquehanna International Group, LLP199,381$438.6K0.00%+141,070+241.9%Added
Manufacturers Life Insurance Company, The229,332$504.5K0.00%+185,047+417.9%Added
Apeiron RIA LLC262,542$577.6K0.17%00.0%Unchanged
BNP Paribas Arbitrage, SA273,945$602.7K0.00%−3,399−1.2%Reduced
Quinn Opportunity Partners LLC280,000$616.0K0.04%−100,000−26.3%Reduced
Nuveen, LLC314,275$691.4K0.00%+314,275New
Jefferies Financial Group Inc.322,600$709.7K0.01%+322,600New
Bank of New York Mellon Corp328,342$722.4K0.00%−12,368−3.6%Reduced
EAM Investors, LLC349,000$767.8K0.13%+349,000New
TD Asset Management Inc394,600$868.1K0.00%+394,600New
Highland Capital Management Fund Advisors, L.P.475,750$1.05M0.10%00.0%Unchanged
Wellington Management Group LLP487,242$1.07M0.00%−880−0.2%Reduced
Citadel Advisors LLC501,490$1.10M0.00%+501,490New
Richmond Brothers, Inc.544,901$1.20M0.76%−97,438−15.2%Reduced
CM Management, LLC600,000$1.32M1.33%−100,000−14.3%Reduced
Two Sigma Advisers, LP669,171$1.47M0.00%−154,700−18.8%Reduced
JPMorgan Chase & Co696,443$1.53M0.00%+133,679+23.8%Added
Bridgeway Capital Management, LLC700,000$1.54M0.04%+400,000+133.3%Added
Stonepine Capital Management, LLC796,100$1.75M2.03%+96,100+13.7%Added
Monaco Asset Management SAM960,000$2.11M1.07%−252,743−20.8%Reduced
Bank of America Corp968,041$2.13M0.00%−78,749−7.5%Reduced
Northern Trust Corp995,394$2.19M0.00%−16,362−1.6%Reduced
Goldman Sachs Group Inc1,028,678$2.26M0.00%+373,518+57.0%Added
Two Sigma Investments, LP1,052,981$2.32M0.01%+62,812+6.3%Added
Clearline Capital LP1,059,911$2.33M0.24%−750,572−41.5%Reduced
Charles Schwab Investment Management Inc1,089,449$2.40M0.00%−16,354−1.5%Reduced
Marshall Wace, LLP1,254,696$2.76M0.00%+237,157+23.3%Added
Millennium Management LLC1,395,285$3.07M0.00%+1,179,754+547.4%Added
Orchard Capital Managment, LLC1,431,758$3.15M2.15%−444,702−23.7%Reduced
New York State Common Retirement Fund1,752,924$3.86M0.01%+431,918+32.7%Added
Morgan Stanley1,933,405$4.25M0.00%−860,785−30.8%Reduced
Congress Park Capital LLC2,035,617$4.48M1.70%−419,878−17.1%Reduced
Tang Capital Management LLC2,235,459$4.92M0.27%+95,188+4.4%Added
Renaissance Technologies LLC2,274,500$5.00M0.01%+1,085,700+91.3%Added
JW Asset Management, LLC2,337,743$5.14M2.91%+45,325+2.0%Added
AIGH Capital Management LLC2,778,200$6.11M3.17%+2,778,200New
D. E. Shaw & Co., Inc.2,986,197$6.57M0.01%−737,509−19.8%Reduced
Price T Rowe Associates Inc3,004,676$6.61M0.00%+2,958,497+6,406.6%Added
Geode Capital Management, LLC3,113,728$6.85M0.00%+98,401+3.3%Added
State Street Corp3,253,904$7.16M0.00%+107,711+3.4%Added
Tejara Capital Ltd4,577,407$10.1M4.96%−84,140−1.8%Reduced
Point72 Asset Management, L.P.4,775,877$10.5M0.03%+1,700,068+55.3%Added
Palisade Capital Management LLC5,286,931$11.6M0.33%+1,360,542+34.7%Added
Velan Capital Investment Management LP6,986,744$15.4M15.81%00.0%Unchanged
Adage Capital Partners GP, L.L.C.7,852,000$17.3M0.03%−648,000−7.6%Reduced
Vanguard Group Inc8,225,585$18.1M0.00%+67,976+0.8%Added
BlackRock, Inc.8,563,419$18.8M0.00%−27,323−0.3%Reduced
Rubric Capital Management LP26,713,503$58.8M1.05%00.0%Unchanged
Proequities, Inc.0$00.00%−1,280−100.0%Sold out
Zweig-DiMenna Associates LLC0$00.00%−128,592−100.0%Sold out
Verition Fund Management LLC0$00.00%−102,843−100.0%Sold out
Aristides Capital LLC0$00.00%−52,849−100.0%Sold out
Arkadios Wealth Advisors0$00.00%−50,000−100.0%Sold out
State of Wyoming0$00.00%−29,736−100.0%Sold out
Engineers Gate Manager LP0$00.00%−27,607−100.0%Sold out
Colony Group, LLC0$00.00%−20,000−100.0%Sold out
Point72 (DIFC) Ltd0$00.00%−18,924−100.0%Sold out
Wolverine Trading, LLC0$00.00%−12,330−100.0%Sold out
Simplex Trading, LLC0$00.00%−7,498−100.0%Sold out
SRS Capital Advisors, Inc.0$00.00%−1,035−100.0%Sold out
R Squared Ltd0$00.00%−990−100.0%Sold out
Jones Financial Companies LLLP0$00.00%−476−100.0%Sold out
Huntington National Bank0$00.00%−370−100.0%Sold out
Eagle Bay Advisors LLC0$00.00%−193−100.0%Sold out
GeoWealth Management, LLC0$00.00%−173−100.0%Sold out
IFP Advisors, Inc0$00.00%−35−100.0%Sold out
Nuveen Asset Management, LLC––––Not filed
Global Retirement Partners, LLC––––Not filed
WR Wealth Planners, LLC––––Not filed